There's a new lipid in town

Article

A new class of lipids, that makes up part of the tear film, has been identified, which could lead to insights into the role of fatty acid amide activity in the human biological system.

A new class of lipids, that makes up part of the tear film, has been identified, which could lead to insights into the role of fatty acid amide activity in the human biological system, according to a study published in the January 2007 issue of Investigative Ophthalmology and Visual Science.

Kelly Nichols and colleagues from the College of Optometry at the Ohio State University, USA, analysed human meibomian gland secretions using electrospray quadrupole time-of-flight mass spectrometry. Mass determination and collision-induced dissociation of meibum and lipid standards were used to identify lipid species.

The researchers findings indicate that oleamide, an endogenous fatty acid primary amide, is a predominant component of meibum. It is already known that oleamide plays a role in the brain, where it helps induce sleep, but this is the first study to identify it in the tear film of the eye.

The researchers hope that further investigation will allow them to work out the lipid?s exact role in the eye.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.